Company / Working Capital
Nuo Therapeutics, Inc. Working Capital History
FY2011-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$248.3K
FY2017
5-year range
-$39.1M / $12.9M
FY2013-FY2017
Trend
-87.1%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital has fluctuated over the past 7 years, ranging from -$39M in FY2015 to $13M in FY2014.
Based on SEC 10-K filings.
$248,270 in FY2017 with a 5-year CAGR of -41.5%.
Improved from -$39M to $248,270 over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -73.2%
- 5-Year CAGR
- -41.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -41.5%, indicating a declining trend.
- In FY2017, working capital decreased 87.1% year-over-year.
- Peak working capital was recorded in FY2014.
- Lowest working capital in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -45.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | $248.3K | -87.1% |
| FY2016 | $1.9M | +104.9% |
| FY2015 | -$39.1M | -403.3% |
| FY2014 | $12.9M | +2227.1% |
| FY2013 | -$606.7K | -116.7% |
| FY2012 | $3.6M | +79.8% |
| FY2011 | $2.0M | - |
As of FY2017 · SEC 10-K · Updated Jun 29, 2026